U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07020793) titled 'Green Subthreshold Laser Therapy for Chronic Central Serous Chorioretinopathy.' on June 03.
Brief Summary: Chronic Central Serous Chorioretinopathy (CSCR) is a vision-threatening retinal disorder characterized by persistent subretinal fluid due to choroidal vascular hyperpermeability and retinal pigment epithelium (RPE) dysfunction. This study evaluates the efficacy and safety of green subthreshold laser therapy using Norlase µSec Technology as a novel, tissue-sparing approach for treating chronic CSCR. By targeting RPE repair without inducing visible retinal damage, this technique aims to resolve subretinal fluid, restore reti...